Mundipharma, through its model of independent associated companies, is aiming to take the lead in the Middle East, Turkey & Africa markets through its continuous commitment to improving peoples' lives. Ashraf Allam, regional VP for the META region, discusses his journey of building Mundipharma's strong footprint in the region and the opportunities that market with more than one billion potential patients has to offer. Allam also explains why this part of the world is an excellent platform to market Mundipharma's innovative treatments, and possibly license many more novel therapies in the future.
Mundipharma operates in a unique way because while it is a multinational company, it operates under the notion of independent associated companies, meaning that each legal entity has independence in terms of operation
